Resources and Insights

WuXi AppTec’s Changzhou and Taixing API Sites Successfully Pass FDA Inspections

WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services

Forum Video: Accelerated Pharmaceutical Development – San Diego

The Role of Benchmarking Critical Impurity Control in Therapeutic Oligonucleotide Phosphoramidites

This poster examines the critical role of benchmarking impurity control in the manufacturing of therapeutic oligonucleotide phosphoramidites, ensuring consistent quality...

WuXi AppTec’s Couvet Site Receives EcoVadis 2024 Silver Medal Rating

Couvet, Switzerland – November 14, 2024 – WuXi AppTec, a global company that provides a broad portfolio of R&D and...

WuXi AppTec Opens New R&D Center in Changzhou, China

New facility enhances the Company’s drug substance process R&D capacity to drive innovation across all synthetic modalities and meet growing...

WuXi AppTec Named Global CRDMO Company of the Year by Frost & Sullivan for the Eighth Consecutive Year

WuXi AppText has been awarded the 2024 Global CRDMO Company of the Year Award by Frost & Sullivan, a growth...

New Enzyme Fermentation Plant in Changshu, China

We’re excited to announce the latest enhancement to our Early Intermediates manufacturing facility in Changshu, China: a new enzyme fermentation...

Mastering and Accelerating sgRNA Synthesis: Unveiling Success Strategies

This poster presents strategies for mastering and accelerating sgRNA synthesis, showcasing WuXi TIDES discovery oligonucleotide capabilities and success strategies for...

Streamline the import and export of drug substance and drug product between China and the US